Publications by authors named "Paul Busse"

Claim this Profile
P
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Steven J Frank, Paul M Busse, J Jack Lee, David I Rosenthal, Mike Hernandez

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.
A Dimitrios Colevas, Anthony J Cmelak, David G Pfister, Sharon Spencer, Douglas Adkins, Paul M Busse

J Natl Compr Canc Netw· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large anatomical changes in head-and-neck cancers - A dosimetric comparison of online and offline adaptive proton therapy.
Mislav Bobić, Arthur Lalonde, Konrad P Nesteruk, Hoyeon Lee, Lena Nenoff, Paul M Busse

Clin Transl Radiat Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
Connor J O'Boyle, Giulia Siravegna, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Paul M Busse

Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
Jimmy J Caudell, Maura L Gillison, Ellie Maghami, Sharon Spencer, David G Pfister, Paul M Busse

J Natl Compr Canc Netw· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.
Grace L Smith, Shuangshuang Fu, Matthew S Ning, Diem-Khanh Nguyen, Paul M Busse

Int J Part Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.
Umair Mahmood, Andrew Bang, Yu-Hui Chen, Raymond H Mak, Jochen H Lorch, Paul M Busse

Int J Radiat Oncol Biol Phys· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial.
Mike Hernandez, J Jack Lee, Beow Y Yeap, Rong Ye, Robert L Foote, Paul Busse

Adv Radiat Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
David G Pfister, Sharon Spencer, David Adelstein, Douglas Adkins, Yoshimi Anzai, Paul M Busse

J Natl Compr Canc Netw· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton therapy for head and neck paragangliomas: A single institutional experience.
Kylie H Kang, Emily S Lebow, Andrzej Niemierko, Marc R Bussière, Nicholas A Dewyer, Paul M Busse

Head Neck· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.
Maximilian Niyazi, Andrzej Niemierko, Harald Paganetti, Matthias Söhn, Emily Schapira, Paul M Busse

Radiother Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beam angle optimization using angular dependency of range variation assessed via water equivalent path length (WEPL) calculation for head and neck proton therapy.
Jihun Kim, Yang-Kyun Park, Gregory Sharp, Paul Busse, Brian Winey

Phys Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
Maria B Koenigs, Armida Lefranc-Torres, Juliana Bonilla-Velez, Krupal B Patel, D Neil Hayes, Paul M Busse

J Natl Cancer Inst· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria Neck Mass-Adenopathy.

J Am Coll Radiol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.
A Dimitrios Colevas, Sue S Yom, David G Pfister, Sharon Spencer, David Adelstein, Paul M Busse

J Natl Compr Canc Netw· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.
Steven J Frank, Pierre Blanchard, J Jack Lee, Erich M Sturgis, Merrill S Kies, Paul M Busse

Semin Radiat Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic and functional outcomes of pretreatment tracheotomy in advanced laryngeal squamous cell carcinoma: A multi-institutional analysis.
Serena A Byrd, Mary J Xu, Lauren M Cass, Daniel J Wehrmann, Matthew Naunheim, Paul Busse

Oral Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
David Adelstein, Maura L Gillison, David G Pfister, Sharon Spencer, Douglas Adkins, Paul M Busse

J Natl Compr Canc Netw· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR appropriateness criteria nasal cavity and paranasal sinus cancers.
Farzan Siddiqui, Richard V Smith, Sue S Yom, Jonathan J Beitler, Paul M Busse

Head Neck· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive proton beam therapy for adenoid cystic carcinoma of the nasopharynx involving the base of skull.
Michelle S Gentile, Darwin Yip, Norbert J Liebsch, Judith A Adams, Paul M Busse

Oral Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Water equivalent path length calculations using scatter-corrected head and neck CBCT images to evaluate patients for adaptive proton therapy.
Jihun Kim, Yang-Kyun Park, Gregory Sharp, Paul Busse, Brian Winey

Phys Med Biol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Jonathan J Beitler, Harry Quon, Christopher U Jones, Joseph K Salama, Paul M Busse

Head Neck· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness criteria® for nasopharyngeal carcinoma.
Nabil F Saba, Joseph K Salama, Jonathan J Beitler, Paul M Busse, Jay S Cooper

Head Neck· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes After Proton Beam Therapy for Sinonasal Squamous Cell Carcinoma.
Andrea L Russo, Judith A Adams, Elizabeth A Weyman, Paul M Busse, Saveli I Goldberg

Int J Radiat Oncol Biol Phys· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
Shlomo A Koyfman, Jay S Cooper, Jonathan J Beitler, Paul M Busse, Christopher U Jones

Head Neck· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis